Dextropropoxyphene: Safety and efficacy in older patients

Drugs and Aging

Volumn 22, Issue 5, 2005, Pages 419-432

  Goldstein, David J ^a,c   Turk, Dennis C ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CODEINE; DEXTROPROPOXYPHENE; DICLOFENAC; DIFLUNISAL; DIHYDROCODEINE; MEPTAZINOL; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; SUPROFEN;

ABDOMINAL PAIN; ADD ON THERAPY; ANALGESIA; ARTHRALGIA; BONE PAIN; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL TRIAL; CONCENTRATION LOSS; CONFUSION; CONSTIPATION; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELDERLY CARE; EUPHORIA; GASTROINTESTINAL SYMPTOM; HIP FRACTURE; HUMAN; INCIDENCE; INDIGESTION; KIDNEY DISEASE; LIVER DISEASE; MYALGIA; NAUSEA; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; SOMNOLENCE; TREATMENT OUTCOME; UROGENITAL TRACT DISEASE; VOMITING;

AGED; ANALGESICS, OPIOID; CLINICAL TRIALS; HUMANS; PAIN; PROPOXYPHENE;

EID: 22344435404     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200522050-00006     Document Type: Review

References (62)

1. Cramer GW, Galer BS, Mendelson MA, et al. A drug use evaluation of selected opioid and nonopioid analgesics in the nursing facility setting. J Am Geriatr Soc 2000; 48: 398-404
2. Mott DA, Meek PD. Evaluating prescriptions for the elderly: drug/age criteria as a tool to help community pharmacists. J Am Pharm Assoc (Wash) 2000; 40: 417-24
3. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly: an update. Arch Intern Med 1997; 157: 1531-6
4. Chernish SM, Finneran J, Gruber Jr CM, et al. The effectiveness of D-propoxyphene hydrochloride and codeine phosphate as determined by two methods of clinical testing for relief of chronic pain. J Pharmacol Exp Ther 1956; 118: 280-5
5. Gruber Jr CM, King EP, Best MM, et al. Clinical bio-assay of oral analgesic activity of propoxyphene (Lilly) acetylsalicylic acid, and codeine phosphate, and observations on placebo reactions. Arch Int Pharmacodyn Ther 1955; 104: 156-66
6. Beaver WT. Analgesic efficacy of dextropropoxyphene and dextropropoxyphene-containing combinations: a review. Hum Toxicol 1984; 3 Suppl.: 191S-220S
7. Lopez-Munoz FJ, Salazar LA. Determination of analgesic inter action between acetaminophen and d-propoxyphene obtained by means of the surface of synergistic interaction. Methods Find Exp Clin Pharmacol 1995; 17: 311-20
8. Jacobson J, Bertilson SO. Analgesic efficacy of paracetamol/codeine and paracetamol/dextropropoxyphene in pain after episiotomy and ruptures in connection with childbirth. J Int Med Res 1987; 15: 89-95
9. Crighton IM, Hobbs GJ, Wrench IJ. Analgesia after day case laparoscopic sterilization. Anesthesia 1997; 52: 649-52
10. Cooper SA, Breen JF, Giuliani RL. The relative efficacy of indoprofen compared with opioid-analgesic combinations. J Oral Surg 1981; 39: 21-5
11. Cooper SA. Double-blind comparison of zomepirac sodium, propoxyphene/acetaminophen, and placebo in the treatment of oral surgical pain. Cur Therapeutic Res 1980; 28: 630-8
12. Forbes JA, Foor VM, Bowser MW, et al. A 12-hour evaluation of the analgesic efficacy of diflunisal, propoxyphene, a propoxyphene-acetaminophen combination and placebo in post-operative oral surgery pain. Pharmacotherapy 1982; 2: 43-9
13. Evans PJD, McQuay HJ, Rolfe M, et al. Zomepirac, placebo, and paracetamol/dextropropoxyphene combination compared in orthopedic postoperative pain. Br J Anaesth 1982; 54: 927-33
14. Winter Jr L, Calman HI, Caruso WA, et al. A double-blind comparison of ethoheptazine citrate, propoxyphene hydrochloride, and placebo. Curr Ther Res Clin Exp 1973; 15: 383-90
15. Sadove MS, Schiffrin MJ, Ali SM. A controlled study of code-ine, dextropropoxyphene and RO 4-11778/1. Am J Med Sci 1962; 241: 103-8
16. Hopkinson JH. Ibuprofen versus propoxyphene hydrochloride and placebo in the relief of postepisiotomy pain. Curr Ther Res Clin Exp 1980; 27: 55-63
17. Berry FN, Miller JM, Levin HM, et al. Relief of severe pain with acetaminophen in a new dose formulation versus propox-yphene hydrochloride 65mg and placebo: a comparative-double blind study. Curr Ther Res Clin Exp 1975; 17: 361-8
18. Bloomfield SDS, Barden TP, Mitchell J. Nefopam and propoxyphene in episiotomy pain. Pharmacol Ther 1980; 27: 502-7
19. Sunshine A, Slafta J, Gruber C. A comparative analgesic study of propoxyphene, fenoprofen, the combination of propoxyphene and fenoprofen, aspirin, and placebo. J Clin Pharm 1978; 18: 556-63
20. Honig S, Murray KA. Surgical pain: zomepirac sodium, propoxyphene/ acetaminophen combination, and placebo. J Clin Pharmacol 1981; 21: 443-8
21. Sunshine A, Olson NZ, Zighelboim I, et al. Analgesic oral efficacy of tramadol hydrochloride in postoperative pain. Clin Pharmacol Ther 1992; 51: 740-6
22. Chan FK, Hung LC, Suen BY, et al. Celecoxib versus diclofenac plus omeprazole in high-risk arthritis patients: re-sults of a randomized double-blind trial. Gastroenterology 2004; 127 (4): 1038-43
23. MacDonald TM, Morant SV, Goldstein JL, et al. Channelling bias and the incidence of gastrointestinal haemorrhage in users of meloxicam, coxibs, and older, non-specific non-steroidal anti-inflammatory drugs. Gut 2003; 52 (9): 1265-70
24. Laine L, Connors LG, Reicin A, et al. Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology 2003; 124 (2): 288-92
25. Peura DA. Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitors. Cleve Clin J Med 2002; 69 Suppl. 1: SI31-SI39.
26. Saray A, Buyukkocak U, Cinel I, et al. Diclofenac and metamizol in postoperative analgesia in plastic surgery. Acta Chir Plast 2001; 43 (3): 71-6
27. Sunshine A, Laska E, Slafta LJ, et al. A comparative analgesia study of propoxyphene hydrochloride, propoxyphene napsy-late, and placebo. Toxicol Appl Pharmacol 1971; 19: 512-8
28. Fick DM, Cooper JW, Wade WE, et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US Consensus Panel of Experts. Arch Intern Med 2003; 163 (22): 2716-24
29. Melander A, Bodin NO, Danielson K, et al. Absorption and elimination of D-propoxyphene, acetyl salicylic acid, and phenazone in a combination tablet (Doleron): comparison be-tween young and elderly subjects. Acta Med Scand 1978; 203: 121-4
30. Flanagan RJ, Johnston A, White AS, et al. Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in young and elderly volunteers after single and multiple dextropropoxyphene dosage. Br J Clin Pharmacol 1989; 28: 463-9
31. Crome P, Gain R, Ghurye R, et al. Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in elderly hos pital patients after single and multiple doses of Distalgesic: preliminary analysis of results. Hum Toxicol 1984; 3 Suppl.: 41S-8S
32. Forman WB. Opioid analgesic drugs in the elderly. Clin Geriatr Med 1996; 12: 489-500
33. Schnitzer TJ. Non-NSAID pharmacologic treatment options for the management of chronic pain. Am J Med 1998; 105: 45S-52S
34. Rao SK, Sharma SK. The efficacy and safety of dolobid and distalgesic in post-traumatic pain and immobility. Br J Clin Pract 1982; 36: 266-69, 285
35. Oro L. A comparison between meptazinol and dextropropoxyphene plus paracetamol in elderly patients with musculoskeletal pains. Curr Med Res Opin 1984; 9: 240-5
36. Lloyd RS, Costello F, Eves MJ, et al. The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextropropoxyphene/ paracetamol tablets in patients with severe osteoarthritis of the hips. Curr Med Res Opin 1992; 13: 37-48
37. Parr G, Darekar B, Fletcher A, et al. Joint pain and quality of life: results of a randomised trial. Br J Clin Pharmacol 1989; 27: 235-42
38. Boyle RW, Solomonson CE, Petersen JR. Analgesic effect of dextropropoxyphene hydrochloride in elderly patients with chronic pain syndromes. Ann Intern Med 1960; 52: 195-200
39. Brooks PM, Dougan MA, Mugford S, et al. Comparative effectiveness of 5 analgesics in patients with rheumatoid arthritis and osteoarthritis. J Rheumatol 1982; 9: 723-6
40. Salzman RT, Brobyn RD. Long-term comparison of suprofen and propoxyphene in patients with osteoarthritis. Pharmacolo-gy 1983; 27 Suppl. 1: 55-64
41. Boissier C, Perpoint B, Laporte-Simitsidis S, et al. Acceptability and efficacy of two associations of paracetamol with a central analgesic (dextropropoxyphene or codeine): comparison in osteoarthritis. J Clin Pharmacol 1992; 32: 990-5
42. Mercadante S, Salvaggio L, Dardanoni G, et al. Dextropropox yphene versus morphine in opioid-naive cancer patients with pain. J Pain Symptom Manage 1998; 15: 76-81
43. Shorr RI, Griffin MR, Daugherty JR, et al. Opioid analgesics and the risk of hip fracture in the elderly: codeine and propox yphene. J Gerontol 1992; 47: M111-5
44. Ensrud KE, Blackwell TL, Mangione CM, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc 2002; 50: 1629-37
45. Guo Z, Wills P, Viitanen M, et al. Cognitive impairment, drug use, and the risk of hip fracture in persons over 75 years old: a community-based prospective study. Am J Epidemiol 1998; 148: 887-92
46. Collins SL, Edwards JE, Moore RA, et al. Single dose dex tropropoxyphene, alone and with paracetamol (acetami-nophen), for postoperative pain. Cochrane Database Syst Rev 2000; (2): CD001440
47. Sloane PD, Coeytaux RR, Rainer BS, et al. Dizziness: state of the science. Ann Intern Med 2001; 134: 823-32
48. Ganguli M, Reynolds CF, Gilby JE. Prevalence and persistence of sleep complaints in a rural older community sample: the MoVIES Project. J Am Geriatr Soc 1996; 44: 778-84
49. Bergeron L, Guy C, Beyens MN, et al. Dextropropoxyphene hepatotoxicity: four cases and literature review. Therapie 2002; 57: 464-72
50. AGS Panel on Persistent Pain in Older Persons. The management of persistent pain in older persons. J Am Geriatr Soc 2002; 50: S205-24
51. Rawal N. Treating postoperative pain improves outcome. Minerva Anesthesiol 2001; 67: S200-5
52. McHugh G, Thomas G. Living with chronic pain: the patient's perspective. Nurs Stand 2001; 15: 33-7
53. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing homes. Arch Intern Med 1991; 151: 1825-32
54. Li Wan Po A, Zhang WY. Systematic overview of co-proxamol to assess analgesic effects of addition of dextropropoxyphene to paracetamol. BMJ 1997; 315: 1565-71
55. Waife SO, Gruber CM, Rodda BE, et al. Analgesia, plasma levels, and dosage of propoxyphene. Int J Clin Pharmacol 1976; 13: 177-81
56. Young RES. A two-dose evaluation of propoxyphene napsylate and codeine in postoperative pain. Curr Ther Res Clin Exp 1978; 24: 495-502
57. Spore DL, Mor V, Larrat P, et al. Inappropriate drug prescription for elderly residents of board and care facilities. Am J Public Health 1997; 87: 404-9
58. Moore RA, McQuay HJ. Single-patient data meta-analysis of 3453 postoperative patients: oral tramadol versus placebo, codeine and combination analgesics. Pain 1997; 69: 287-94
59. Hawton K, Simkin S, Deeks J. Co-proxamol and suicide: a study of national mortality statistics and non-fatal self poisonings. BMJ 2003; 326: 463-9
60. Sturrock RD. Distalgesic; safety and efficacy. Efficacy: UK experience. Hum Toxicol 1984; 3 Suppl.: 221S-7S
61. Finkle BS. Self-poisoning with dextropropoxyphene and dex-tropropoxyphene compounds: the USA experience. Hum Tox icol 1984; 3: 115S-34S
62. Collins SL, Edwards JE, Moore RA, et al. Single-dose dex-tropropoxyphene in post-operative pain: a quantitative systematic review. Eur J Clin Pharmacol 1998; S4: 107-12